Table 2.

The infantile haemangioma therapeutic response and treatment duration.

	Clinical response		p-value	Treatment duration	p-value
	III + IV	Rate		$\overline{\mathit{X}}\mathbf{\pm }\mathit{S}$ (months)
Age (months)			0.030		0.375
1–3	62	84.93%		10.58 ± 4.55
4–6	65	98.48%		9.89 ± 4.97
7–9	21	95.45%		8.59 ± 4.97
10–12	7	87.50%		9.25 ± 4.61
Type			0.716		0.033
Superficial	17	94.44%		10.50 ± 5.01
Deep	20	95.24%		12.43 ± 3.99
Mixed	118	90.77%		9.52 ± 4.79
Location			0.020		0.284
Parotid	26	100.00%		10.92 ± 4.49
Perioral	22	91.67%		10.21 ± 4.84
Periorbital	17	100.00%		9.06 ± 5.67
Perinasal	13	72.22%		9.83 ± 4.07
Oral mucosa	15	93.75%		11.56 ± 5.21
Cheek	12	100.00%		10.50 ± 4.94
Cranium	11	84.62%		6.77 ± 2.22
Periauricular	10	83.33%		11.00 ± 6.19
Forehead	5	71.43%		7.57 ± 3.06
Neck	5	100.00%		11.60 ± 3.0
Zygoma	2	100.00%		8, 12
Occiput	1	100.00%		4
Multiple	16	100.00%		10.13 ± 4.39
Total	155	91.72%		9.99 ± 4.82